Veracyte Inc VCYT:NASDAQ

Last Price$24.66NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/23/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$22.63 (2)
Ask (Size)$26.33 (10)
Day Low / HighN/A - N/A
Volume310.6 K

Veracyte Shares Positive Data That Its Envisia Genomic Classifier Improves Diagnosis of Interstitial Lung Diseases

9:57AM ET 4/02/2019 MT Newswires
Veracyte (VCYT) said late Monday that data published online in The Lancet Respiratory Medicine suggest that use of the company's Envisia Genomic Classifier improves diagnosis for patients undergoing evaluation for interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF).

According to the statement, the Envisia classifier is the first commercially available test that could help distinguish IPF from other ILDs, without the need for surgery.

The Envisia classifier recently received Medicare coverage, making it the first test of its kind for improving IPF diagnosis to be covered for the nation's 55 million Medicare patients.

Price: 25.13, Change: +0.06, Percent Change: +0.24